Brain, Vol. 125, No. 9, 2036-2043,
September 2002
© 2002 Guarantors of Brain
Aß 17–42 in Alzheimer’s disease activates JNK and caspase-8 leading to neuronal apoptosis
0 Molecular Neurobiology Unit, Laboratory of Cellular and Molecular Biology, National Institute on Aging, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA
Correspondence to: J. W. Kusiak PhD or Wanli Wei PhD MD, Molecular Neurobiology, Laboratory of Cellular and Molecular Biology, Intramural Research Program, GRC, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224-6825, USA E-mail: jk133r{at}nih.gov or wanliwei{at}hotmail.com
The p3 peptide [amyloid ß-peptide (Aß) 17–40/42], derived by 
- and 
-secretase cleavage of the amyloid precursor protein (APP), is a major constituent of diffuse plaques in Alzheimer’s disease and cerebellar pre-amyloid in Down’s syndrome. However, the importance of p3 peptide accumulation in Alzheimer’s disease and its toxic properties is not clear. Here, we demonstrate that treatment of cells with Aß 17–42 leads to apoptosis in two human neuroblastoma cell lines, SH-SY5Y and IMR-32. Aß 17–42 activated caspase-8 and caspase-3, induced poly(ADP-ribose) polymerase cleavage, but did not activate caspase-9. Selective caspase-8 and caspase-3 inhibitors completely blocked Aß 17–42-induced neuronal death. Aß 17–42 moderately activated c-Jun N-terminal kinase (JNK); however, overexpression of a dominant-negative mutant of SEK1, the upstream kinase of JNK, protected against Aß 17–42 induced neuronal death. These results demonstrate that Aß 17–42 induced neuronal apoptosis via a Fas-like/caspase-8 activation pathway. Our findings reveal the previously unrecognized toxic effect of Aß 17–42. We propose that Aß 17–42 constitutes an additional toxic peptide derived from APP proteolysis and may thus contribute to the neuronal cell loss characteristic of Alzheimer’s disease.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Ren, H. W. Xu, F. Davey, M. Taylor, J. Aiton, P. Coote, F. Fang, J. Yao, D. Chen, J. X. Chen, et al. Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients J. Biol. Chem., February 29, 2008; 283(9): 5685 - 5691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xie, Y. Dong, U. Maeda, W. Xia, and R. E. Tanzi RNA Interference Silencing of the Adaptor Molecules ShcC and Fe65 Differentially Affect Amyloid Precursor Protein Processing and Abeta Generation J. Biol. Chem., February 16, 2007; 282(7): 4318 - 4325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Patton, W. M. Kalback, C. L. Esh, T. A. Kokjohn, G. D. Van Vickle, D. C. Luehrs, Y.-M. Kuo, J. Lopez, D. Brune, I. Ferrer, et al. Amyloid-{beta} Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis Am. J. Pathol., September 1, 2006; 169(3): 1048 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity J. Cell Biol., April 25, 2005; 169(2): 331 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Li, L. Yang, K. Lindholm, Y. Konishi, X. Yue, H. Hampel, D. Zhang, and Y. Shen Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid-{beta} Protein-Induced Neuron Death J. Neurosci., February 18, 2004; 24(7): 1760 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schmechel, H. Zentgraf, S. Scheuermann, G. Fritz, R. Pipkorn, J. Reed, K. Beyreuther, T. A. Bayer, and G. Multhaup Alzheimer {beta}-Amyloid Homodimers Facilitate A{beta} Fibrillization and the Generation of Conformational Antibodies J. Biol. Chem., September 12, 2003; 278(37): 35317 - 35324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Dho and K.-S. Kwon The Ret Finger Protein Induces Apoptosis via Its RING Finger-B Box-Coiled-coil Motif J. Biol. Chem., August 22, 2003; 278(34): 31902 - 31908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Minogue, A. W. Schmid, M. P. Fogarty, A. C. Moore, V. A. Campbell, C. E. Herron, and M. A. Lynch Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-{beta} on Long Term Potentiation and Cell Death in Hippocampus: A ROLE FOR INTERLEUKIN-1{beta}? J. Biol. Chem., July 18, 2003; 278(30): 27971 - 27980. [Abstract] [Full Text] [PDF]
|
|